💨 Abstract
India's leading pharmaceutical companies are projected to achieve strong sales growth of up to 16% YoY in FY 2024-25, primarily due to robust domestic formulations performance and moderate US sales improvement. Key players like Sun Pharma, Cipla, Dr Reddy's Laboratories, Torrent Pharma, and JB Chemicals are covered in the report.
Courtesy: theprint.in
Summarized by Einstein Beta 🤖
Suggested
Pujashree, An India-Based Start-Up Raises INR 12 Crore Seed Capital With An Aim To Redefine Spiritual Consumption In India
Nitish should be made Dy PM, says senior BJP leader Choubey
Felt like some movie was on: Delhi CM Rekha Gupta on announcement of her name for post
Latur mephedrone unit bust: Two accused from Mumbai, Thane remanded in 14-day judicial custody
UP: Soldier on leave to testify in murder case shot dead in Saharanpur
Mantra Expands Luxury Portfolio with Burgundy & Closes a Blockbuster Financial Year
Namo Bharat trains: Overhead Equipment on New Ashok Nagar-Sarai Kale Khan route charged
Bihar Strengthens Digital Transformation with Bidgely's AI-Driven Power Solutions
Mumbai Business Conclave 2025: A Global Business Powerhouse Event to Be Held at Taj Santacruz on April 12
Fake flight ticket booking racket busted, two held
Powered by MessengerX.io